CN101912376A - 双层结构的苦参碱阴道泡腾片及制备方法 - Google Patents
双层结构的苦参碱阴道泡腾片及制备方法 Download PDFInfo
- Publication number
- CN101912376A CN101912376A CN 201010258405 CN201010258405A CN101912376A CN 101912376 A CN101912376 A CN 101912376A CN 201010258405 CN201010258405 CN 201010258405 CN 201010258405 A CN201010258405 A CN 201010258405A CN 101912376 A CN101912376 A CN 101912376A
- Authority
- CN
- China
- Prior art keywords
- preparation
- matrine
- vagina
- aperture
- effervescent formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 57
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 title claims abstract description 50
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 title claims abstract description 50
- 229930014456 matrine Natural products 0.000 title claims abstract description 50
- 239000007938 effervescent tablet Substances 0.000 title description 4
- 239000003814 drug Substances 0.000 claims abstract description 37
- 208000004926 Bacterial Vaginosis Diseases 0.000 claims abstract description 13
- 201000010099 disease Diseases 0.000 claims abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 11
- 206010046914 Vaginal infection Diseases 0.000 claims abstract description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 81
- 210000001215 vagina Anatomy 0.000 claims description 68
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 46
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 46
- 239000000203 mixture Substances 0.000 claims description 40
- 239000008187 granular material Substances 0.000 claims description 27
- 238000009472 formulation Methods 0.000 claims description 25
- 235000015165 citric acid Nutrition 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 23
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 23
- 229920002472 Starch Polymers 0.000 claims description 22
- 239000008107 starch Substances 0.000 claims description 22
- 235000019698 starch Nutrition 0.000 claims description 22
- 235000019359 magnesium stearate Nutrition 0.000 claims description 20
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 18
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 18
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 18
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 18
- 238000000465 moulding Methods 0.000 claims description 15
- 241000222122 Candida albicans Species 0.000 claims description 13
- 206010007134 Candida infections Diseases 0.000 claims description 13
- 201000003984 candidiasis Diseases 0.000 claims description 13
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 9
- 239000011230 binding agent Substances 0.000 claims description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 239000007779 soft material Substances 0.000 claims description 6
- 229920003081 Povidone K 30 Polymers 0.000 claims description 5
- 201000008100 Vaginitis Diseases 0.000 claims description 4
- 208000015181 infectious disease Diseases 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- XWBADQOPXPRKBX-FMIVXFBMSA-N 1-n,1-n-diethyl-4-n-[6-methoxy-2-[(e)-2-(4-nitrophenyl)ethenyl]quinolin-4-yl]pentane-1,4-diamine Chemical compound N=1C2=CC=C(OC)C=C2C(NC(C)CCCN(CC)CC)=CC=1\C=C\C1=CC=C([N+]([O-])=O)C=C1 XWBADQOPXPRKBX-FMIVXFBMSA-N 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 239000003716 antitrichomonal agent Substances 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 abstract description 19
- 208000037009 Vaginitis bacterial Diseases 0.000 abstract description 11
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 230000000638 stimulation Effects 0.000 abstract description 3
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 abstract 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 abstract 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 239000003826 tablet Substances 0.000 description 25
- 229940079593 drug Drugs 0.000 description 22
- 230000000694 effects Effects 0.000 description 14
- 239000002253 acid Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 238000011282 treatment Methods 0.000 description 11
- 239000003513 alkali Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000000829 suppository Substances 0.000 description 8
- 208000027709 Vulvovaginal disease Diseases 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 229960004756 ethanol Drugs 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 210000003756 cervix mucus Anatomy 0.000 description 5
- 206010047786 Vulvovaginal discomfort Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 150000007516 brønsted-lowry acids Chemical class 0.000 description 2
- 150000007528 brønsted-lowry bases Chemical class 0.000 description 2
- 206010008323 cervicitis Diseases 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- -1 KOH amine Chemical class 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000003988 chronic cervicitis Diseases 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940037348 metronidazole 200 mg Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102584057A CN101912376B (zh) | 2010-08-20 | 2010-08-20 | 双层结构的苦参碱阴道泡腾片及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102584057A CN101912376B (zh) | 2010-08-20 | 2010-08-20 | 双层结构的苦参碱阴道泡腾片及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101912376A true CN101912376A (zh) | 2010-12-15 |
CN101912376B CN101912376B (zh) | 2011-06-29 |
Family
ID=43320133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102584057A Active CN101912376B (zh) | 2010-08-20 | 2010-08-20 | 双层结构的苦参碱阴道泡腾片及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101912376B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102225090A (zh) * | 2011-06-15 | 2011-10-26 | 江西施美制药有限公司 | 一种苦参泡腾片的制备工艺 |
US9884049B2 (en) | 2014-07-14 | 2018-02-06 | Orion Biotechnology Canada Ltd. | Microbicidal composition comprising an octoxynol and a quinolizidine alkaloid compound or a source thereof |
CN111920847A (zh) * | 2020-09-25 | 2020-11-13 | 贵阳新天药业股份有限公司 | 苦参总碱在制备治疗细菌性阴道病药物中的用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1439370A (zh) * | 2003-02-18 | 2003-09-03 | 宁夏元康医药新技术有限公司 | 苦参碱阴道泡腾片 |
CN101422461A (zh) * | 2007-12-11 | 2009-05-06 | 北京琥珀光华医药科技开发有限公司 | 苦参碱阴道泡腾片的制备方法及其应用 |
-
2010
- 2010-08-20 CN CN2010102584057A patent/CN101912376B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1439370A (zh) * | 2003-02-18 | 2003-09-03 | 宁夏元康医药新技术有限公司 | 苦参碱阴道泡腾片 |
CN101422461A (zh) * | 2007-12-11 | 2009-05-06 | 北京琥珀光华医药科技开发有限公司 | 苦参碱阴道泡腾片的制备方法及其应用 |
Non-Patent Citations (1)
Title |
---|
《药用辅料手册(第四版)》 20050131 郑俊民 主译 692-694 1-10 , 1 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102225090A (zh) * | 2011-06-15 | 2011-10-26 | 江西施美制药有限公司 | 一种苦参泡腾片的制备工艺 |
CN102225090B (zh) * | 2011-06-15 | 2012-11-14 | 江西施美制药有限公司 | 一种苦参泡腾片的制备工艺 |
US9884049B2 (en) | 2014-07-14 | 2018-02-06 | Orion Biotechnology Canada Ltd. | Microbicidal composition comprising an octoxynol and a quinolizidine alkaloid compound or a source thereof |
CN111920847A (zh) * | 2020-09-25 | 2020-11-13 | 贵阳新天药业股份有限公司 | 苦参总碱在制备治疗细菌性阴道病药物中的用途 |
Also Published As
Publication number | Publication date |
---|---|
CN101912376B (zh) | 2011-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101744833B (zh) | 一种治疗细菌性阴道炎的药物组合物 | |
CN101698101B (zh) | 一种治疗阴道炎的药物组合物 | |
CN108635585A (zh) | 一种治疗老年性阴道炎的药物组合物及温敏缓释凝胶剂和制备方法 | |
CN101732342B (zh) | 口服补液盐泡腾片及其应用 | |
CN101912376B (zh) | 双层结构的苦参碱阴道泡腾片及制备方法 | |
CN102038679B (zh) | 一种双唑泰阴道凝胶及其制备方法 | |
CN109453169B (zh) | 草乌甲素的用途 | |
CN104161763B (zh) | 一种药物组合物作为制备治疗皮炎湿疹中的应用 | |
JP4791358B2 (ja) | 真菌の重感染と真菌の再発の処置のためのアスコルビン酸を含んでなる製薬学的組成物 | |
CN101450053A (zh) | 甲硝唑口腔溃疡双层贴片及其制备方法 | |
CN1304002C (zh) | 塞克硝唑阴道泡腾片及其生产方法 | |
CN106581172B (zh) | 用于防治霉菌性、滴虫性和老年性阴道炎的药物及制备方法 | |
CN103405471A (zh) | 一种含有艾普拉唑钠的复方制剂 | |
CN1899392A (zh) | 一种用于治疗妇科炎症的中药组合物及其制备方法和应用 | |
CN105326954A (zh) | 一种治疗睑缘炎的中药组合物及其制备方法 | |
RU2486913C1 (ru) | Средство для спринцевания влагалища в первую фазу лечения бактериального вагиноза | |
CN102935218A (zh) | 一种临床护理上用于治疗褥疮的中药组合物 | |
CN103830222A (zh) | 黄芩素在制备治疗口腔溃疡药物中的应用 | |
RU2486912C1 (ru) | Средство для спринцевания влагалища в первую фазу лечения кандидозного кольпита (молочницы) | |
CN102125559A (zh) | 一种含有己酮可可碱和卡络磺钠的药物组合物及其用途 | |
CN101069680B (zh) | 2-羟基-4-甲基苯磺酸在制备药物中的应用 | |
CN107837274A (zh) | 一种膳食纤维组合物的用途 | |
CN100402037C (zh) | 一种治疗外阴和/或阴道疾病的药物组合物 | |
CN100443082C (zh) | 奥硝唑生物粘贴片及其制备方法 | |
CN101209300A (zh) | 一种花红分散片及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20101215 Assignee: Disai Bio Pharmaceutical Co.,Ltd. Xian Assignor: Wu Jianzhong Contract record no.: 2017610000012 Denomination of invention: Matrine vaginal effervescent tablets with bilayer structure and preparation method Granted publication date: 20110629 License type: Exclusive License Record date: 20170502 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170608 Address after: Hongmiaopo Lianhu District 710016 Shaanxi city of Xi'an province No. 69 Patentee after: Disai Bio Pharmaceutical Co.,Ltd. Xian Address before: 710016 Shaanxi city in Xi'an Province, Xi'an City, No. 69 Patentee before: Wu Jianzhong |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Matrine vaginal effervescent tablet with double-layer structure and its preparation method Effective date of registration: 20220505 Granted publication date: 20110629 Pledgee: Industrial and Commercial Bank of China Limited Xi'an Lianhu road sub branch Pledgor: Disai Bio Pharmaceutical Co.,Ltd. Xian Registration number: Y2022610000218 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230612 Granted publication date: 20110629 Pledgee: Industrial and Commercial Bank of China Limited Xi'an Lianhu road sub branch Pledgor: Disai Bio Pharmaceutical Co.,Ltd. Xian Registration number: Y2022610000218 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Matrine vaginal Effervescent tablet with double-layer structure and preparation method Effective date of registration: 20230616 Granted publication date: 20110629 Pledgee: Industrial and Commercial Bank of China Limited Xi'an Weiyang Branch Pledgor: Disai Bio Pharmaceutical Co.,Ltd. Xian Registration number: Y2023610000455 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |